Apigenin Impedes Cell Cycle Progression at G₂ Phase in Prostate Cancer Cells

Researchers demonstrated that apigenin arrests prostate cancer cells at G₂ phase by flow cytometric analysis of prostate cancer cells co-stained for phospho-Histone H3 and DNA.